Dr. Mehmet Teomete

Abstract P4-11-03: Prediciting high risk hormone receptor (HR) positive Her-2 negative early breast cancer (BC) by artificial intelligence (AI) algorithms

Clinical Cancer Research, 2025

DOI 10.1158/1557-3265.sabcs24-p4-11-03 Quelle: OpenAlex

Recommendations for cyclin‑dependent kinase 4/6 inhibitor treatments in the context of co‑morbidity and drug interactions (Review)

Oncology Letters, 2024

DOI 10.3892/ol.2024.14278 PMID 38385117 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Beyond traditional therapies: clinical significance of complex molecular profiling in patients with advanced solid tumours—results from a Turkish multi-centre study

Japanese Journal of Clinical Oncology, 2024

DOI 10.1093/jjco/hyae002 PMID 38271177 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic Significance of Tumor Tissue NeuGcGM3 Ganglioside Expression in Patients Receiving Racotumomab Immunotherapy

Journal of Oncology, 2020

DOI 10.1155/2020/1360431 PMID 32670370 5 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

2008P The effect of the use of complex molecular profiling in advanced solid organ tumours on clinical decision: Turkey molecular profiling in advanced cancers trial (TUMPACT)

Annals of Oncology, 2020

DOI 10.1016/j.annonc.2020.08.1314 Frei zugänglicher VolltextQuelle: OpenAlex

Prognostic significance of tumour tissue NeuGcGM3 ganglioside expression and predictive value of circulating tumour cell count monitoring in patients receiving racotumomab immunotherapy

Annals of Oncology, 2019

DOI 10.1093/annonc/mdz253.091 Quelle: OpenAlex

Comparison of SP142 (Ventana) and SP263 (Ventana) assays to test PD-L1 expression in metastatic cancer patients to be treated with immune checkpoint inhibitors.

Journal of Clinical Oncology, 2018

DOI 10.1200/jco.2018.36.15_suppl.e24306 Quelle: OpenAlex

Clinical Outcome of Turkish Metastatic Breast Cancer Patients with Currently Available Treatment Modalities - Single Center Experience

Asian Pacific Journal of Cancer Prevention, 2014

DOI 10.7314/apjcp.2014.15.1.117 PMID 24528011 8 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Associations between clinicopathological prognostic factors and pAkt, pMAPK and topoisomerase II expression in breast cancer.

Europe PMC (PubMed Central), 2014

PMID 24995112 1 Zitation (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

Journal of Clinical Oncology, 2012

DOI 10.1200/jco.2012.30.15_suppl.e16015 Frei zugänglicher VolltextQuelle: OpenAlex

Docetaxel, cisplatin, and 5-fluorouracil-based induction chemotherapy followed by concurrent chemoradiotherapy with cisplatin in locally advanced stage III and IV nasopharyngeal cancer.

Kocaeli Üniversitesi - AVESİS, 2012

Quelle: OpenAlex

Efficacy, safety and prognostic features of resected colon carcinoma treated in "real world" practice: a retrospective cohort-study.

PubMed, 2011

PMID 21766495 Frei zugänglicher VolltextQuelle: OpenAlex

Weight gain after adjuvant chemotherapy in patients with early breast cancer in Istanbul Turkey

Medical Oncology, 2010

DOI 10.1007/s12032-010-9463-x PMID 20306160 17 Zitationen (Europe PMC) Quelle: OpenAlex

Pregnancy a short time after multimodal therapy for bilateral breast cancer: A case report and review of literature

Journal of Oncology Pharmacy Practice, 2010

DOI 10.1177/1078155210384755 PMID 20858636 2 Zitationen (Europe PMC) Quelle: OpenAlex

Weight gain after adjuvant chemotherapy in early breast cancer patients in Istanbul.

Journal of Clinical Oncology, 2010

DOI 10.1200/jco.2010.28.15_suppl.e11099 Quelle: OpenAlex

A case of Kikuchi-Fujimoto disease misdiagnosed as Hodgkin's lymphoma: the importance of second opinion.

PubMed, 2009

PMID 19650184 3 Zitationen (Europe PMC) Frei zugänglicher VolltextQuelle: OpenAlex

Impact of dose reductions of platinum compounds on survival in stage IIIB/IV non-small cell lung cancer (NSCLC)

Journal of Clinical Oncology, 2009

DOI 10.1200/jco.2009.27.15_suppl.e19055 Frei zugänglicher VolltextQuelle: OpenAlex

Weight gain after adjuvant treatment in breast cancer patients in Istanbul, Turkey

Journal of Clinical Oncology, 2009

DOI 10.1200/jco.2009.27.15_suppl.e11620 Quelle: OpenAlex

Pulmonary toxicity in patients receiving docetaxel chemotherapy

Journal of Clinical Oncology, 2009

DOI 10.1200/jco.2009.27.15_suppl.e13532 Frei zugänglicher VolltextQuelle: OpenAlex

The relationship between glycemic control and platelet activity in type 2 diabetes mellitus

Journal of Diabetes and its Complications, 2008

DOI 10.1016/j.jdiacomp.2008.01.006 PMID 18358749 110 Zitationen (Europe PMC) Quelle: OpenAlex

Clinical features and outcome of adjuvant chemoradiotherapy in Turkish rectal carcinoma patients: Single institution experience

Journal of Clinical Oncology, 2008

DOI 10.1200/jco.2008.26.15_suppl.15103 Quelle: OpenAlex

Clinical outcome of triple-negative (TN) breast cancer (BC)

Journal of Clinical Oncology, 2008

DOI 10.1200/jco.2008.26.15_suppl.11526 Quelle: OpenAlex

Benefit from adjuvant anthracyclines according to hormone receptor status

Journal of Clinical Oncology, 2008

DOI 10.1200/jco.2008.26.15_suppl.11513 Frei zugänglicher VolltextQuelle: OpenAlex

Outcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital

Journal of Clinical Oncology, 2007

DOI 10.1200/jco.2007.25.18_suppl.14588 Quelle: OpenAlex

Clinical outcome of node-negative (NN) breast cancer (BC) patients

Journal of Clinical Oncology, 2007

DOI 10.1200/jco.2007.25.18_suppl.11102 Frei zugänglicher VolltextQuelle: OpenAlex

P2-323: Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

Journal of Thoracic Oncology, 2007

DOI 10.1097/01.jto.0000284031.87598.62 Frei zugänglicher VolltextQuelle: OpenAlex

Outcome of rectal carcinoma patients receiving adjuvant chemoradiotherapy in Marmara University Hospital

Journal of Clinical Oncology, 2006

DOI 10.1200/jco.2006.24.18_suppl.13584 Quelle: OpenAlex

Outcome of adjuvant treatment in turkish breast cancer (BC) patients (PTS): Single institution experience

Kocaeli Üniversitesi - AVESİS, 2006

Quelle: OpenAlex

Outcome of metastatic colorectal cancer patients receiving palliative chemotherapy in Marmara University Hospital

Kocaeli Üniversitesi - AVESİS, 2006

Quelle: OpenAlex

Outcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

Kocaeli Üniversitesi - AVESİS, 2006

Quelle: OpenAlex

0utcome of metastatic colorectal cancer patients receiving second line chemotherapy in Marmara University Hospital F. Dane, M. Gumus, A. Ozturk, F. Yumuk, S. Iyikesici, G. Basaran, D. Cabuk, M. Teomete and N. S. Turhal

Quelle: Profilseite auf acibadem.com.tr

0utcome of patients with stage III and IV non-small cell lung cancer in Marmara University Hospital, Istanbul, Turkey

Quelle: Profilseite auf acibadem.com.tr